| Treatment effect: |  | a) Within group analyses |  | ||
---|---|---|---|---|---|---|
 | TF-CBT |  | TAU |  | ||
Outcome | Estimate | 95% CI | p | Estimate | 95% CI | p |
CES-D | -3.88 | - 6.37 to -1.38 | .003 | 0.68 | -1.90 to 3.28 | .603 |
 T2 vs T1 | -6.73 | - 9.19 to -4.27 | <.001 | -2.78 | -5.35 to -0.21 | .034 |
 T3 vs T1 |  |  |  |  |  |  |
PERQ | Â | Â | Â | Â | Â | Â |
 T2 vs T1 | -5.80 | - 8.51 to -3.01 | <.001 | -3.83 | -6.71 to -0.95 | .010 |
 T3 vs T1 | -8.71 | -11.35 to -6.02 | <.001 | -4.27 | -7.06 to -1.49 | .003 |
 | Treatment Effect | b Between group | Interaction: Time by Group | |||
Outcome | Estimate | 95% CI | p | p | ||
CES-D | Â | Â | Â | Â | ||
 TF-CBT vs TAU T3 | 3.62 | -0.61 to 7.86 | .094 | .022 | ||
PERQ | Â | Â | Â | Â | ||
 TF-CBT vs TAU T3 | 2.95 | -1.12 to 7.01 | .154 | .078 |